The former chairman of troubled IOOF told APRA during a review meeting that he “struggled” to think the wealth manager had any conflicts of interest and that the issue was getting too much “airplay”, according to court documents filed recently by the prudential regulator.
After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker’s plans to market a competing insulin injector pen in Australia.
The operator of a Vietnamese mine has filed a lawsuit seeking to enforce a $132 million arbitration judgment against engineering company Jacobs E&C, which was acquired by WorleyParsons in December.
Jones Day has bolstered its global disputes practice in Melbourne, bringing on experienced international dispute resolution lawyer Leah Ratcliff from BHP.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly “inconsistent” pleadings.
The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant’s appeal “misconceived”.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.
An Australian partner of international law firm Jones Day has moved to the firm’s Singapore office to bolster its growing team of international arbitration specialists.
International law firm Jones Day has expanded its intellectual property team in Sydney, hiring experienced patent litigator Andrew Rankine from Ashurst as its second local partner.